# S(+)-Ibuprofen Effects on Asprin Treated Volunteers

> **NCT00442585** · PHASE1 · COMPLETED · sponsor: **Gebro Pharma GmbH** · enrollment: 72 (—)

## Conditions studied

- Drug Interactions

## Interventions

- **DRUG:** S(+)-ibuprofen

## Key facts

- **NCT ID:** NCT00442585
- **Lead sponsor:** Gebro Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 72 (—)
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00442585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00442585, "S(+)-Ibuprofen Effects on Asprin Treated Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00442585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
